Silo Pharma, Inc. (SILO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 18.03K | 18.03K | 18.02K | 18.02K | 18.03K | 18.03K | 18.02K | 18.02K | 18.03K | 18.03K | 18.02K | 18.02K |
| Revenue Growth % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Cost of Goods Sold | 266.26K | 20.69K | 20.69K | 1.46K | 1.46K | 399.86K | 1.46K | 1.46K | 1.46K | 1.46K | 1.46K | 1.46K |
| COGS % of Revenue | 1477.08% | 114.77% | 114.77% | 8.09% | 8.1% | 2218.26% | 8.09% | 8.09% | 8.1% | 8.1% | 8.09% | 8.09% |
| Gross Profit | -248.23K | -2.66K | -2.66K | 16.57K | 16.57K | -381.84K | 16.57K | 16.57K | 16.57K | 16.57K | 16.57K | 16.57K |
| Gross Margin % | -1377.08% | -14.77% | -14.77% | 91.91% | 91.9% | -2118.26% | 91.91% | 91.91% | 91.9% | 91.9% | 91.91% | 91.91% |
| Gross Profit Growth % | -1598.44% | 99.3% | -116.07% | 0% | 0% | -2404.94% | 0% | 0% | 0% | 0% | 0% | 0% |
| Operating Expenses | 1.35M | 783.86K | 1.15M | 1.27M | 1.11M | 1.5M | 1.03M | 1.02M | 896.08K | 1.18M | 789.96K | 1.13M |
| OpEx % of Revenue | 7469.37% | 4348.5% | 6373.39% | 7018.68% | 6161.58% | 8295.91% | 5695.54% | 5655.15% | 4971.04% | 6547.71% | 4382.6% | 6277.68% |
| Selling, General & Admin | 333.16K | 477.86K | 605.19K | 547.87K | 516.73K | 419.7K | 509.07K | 626.52K | 577.84K | 843.33K | 615.47K | 1M |
| SG&A % of Revenue | 1848.24% | 2650.93% | 3357.5% | 3039.5% | 2866.55% | 2328.31% | 2824.26% | 3475.82% | 3205.59% | 4678.38% | 3414.53% | 5552.47% |
| Research & Development | 1.01M | 306K | 543.62K | 717.25K | 593.96K | 1.08M | 517.55K | 392.82K | 318.24K | 336.96K | 174.5K | 130.72K |
| R&D % of Revenue | 5621.13% | 1697.58% | 3015.89% | 3979.18% | 3295.03% | 5967.6% | 2871.28% | 2179.33% | 1765.45% | 1869.33% | 968.07% | 725.21% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.59M | -786.52K | -1.15M | -1.25M | -1.09M | -1.88M | -1.01M | -1M | -879.51K | -1.16M | -773.4K | -1.11M |
| Operating Margin % | -8846.44% | -4363.28% | -6388.16% | -6926.77% | -6069.68% | -10414.16% | -5603.63% | -5563.24% | -4879.14% | -6455.84% | -4290.7% | -6185.77% |
| Operating Income Growth % | -45.75% | 58.1% | -14% | -24.51% | -24.4% | -61.31% | -30.6% | 10.06% | -9.46% | 29.77% | 18.52% | -125.58% |
| EBITDA | -1.59M | -783.59K | -1.15M | -1.25M | -1.09M | -1.87M | -1.01M | -929.92K | -799.8K | -1.11M | -659.08K | -1.01M |
| EBITDA Margin % | -8830.15% | -4346.98% | -6371.86% | -6913.05% | -6052.53% | -10397% | -5586.48% | -5159.06% | -4436.91% | -6143.56% | -3656.49% | -5609.36% |
| EBITDA Growth % | -45.89% | 58.19% | -14.06% | -34% | -36.41% | -69.23% | -52.78% | 8.03% | 11.6% | 42.16% | 32.97% | -53.57% |
| D&A (Non-Cash Add-back) | 2.94K | 2.94K | 2.94K | 2.47K | 3.09K | 3.09K | 3.09K | 0 | 0 | 56.29K | 0 | 0 |
| EBIT | -1.64M | -848.83K | -1.11M | -1.2M | -1.03M | -1.79M | -927.73K | -929.92K | -799.8K | -1.05M | -659.08K | -1.01M |
| Net Interest Income | 35.34K | 9.86K | 43.72K | 43.27K | 59.76K | 82.73K | 83.86K | 75.18K | 86.31K | 108.11K | 115.1K | 107.72K |
| Interest Income | 38.72K | 42.56K | 44.6K | 44.92K | 61.83K | 83.01K | 84.94K | 77.04K | 88.18K | 108.38K | 116.18K | 109.58K |
| Interest Expense | 3.37K | 32.7K | 886 | 1.65K | 2.07K | 274 | 1.08K | 1.86K | 1.87K | 273 | 1.08K | 1.86K |
| Other Income/Expense | -52.46K | -95.01K | 41.03K | 44.26K | 62.68K | 146.64K | 81.24K | 71K | 77.85K | 112.15K | 113.24K | 102.03K |
| Pretax Income | -1.65M | -881.53K | -1.11M | -1.2M | -1.03M | -1.73M | -928.81K | -931.78K | -801.67K | -1.05M | -660.16K | -1.01M |
| Pretax Margin % | -9137.45% | -4890.33% | -6160.54% | -6681.24% | -5721.94% | -9600.69% | -5152.92% | -5169.37% | -4447.28% | -5833.66% | -3662.47% | -5619.7% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.65M | -881.53K | -1.11M | -1.2M | -1.03M | -1.73M | -928.81K | -931.78K | -801.67K | -1.12M | -660.16K | -1.01M |
| Net Margin % | -9137.45% | -4890.33% | -6160.54% | -6681.24% | -5721.94% | -9600.69% | -5152.92% | -5169.37% | -4447.28% | -6219.77% | -3662.47% | -5619.7% |
| Net Income Growth % | -59.69% | 49.06% | -19.55% | -29.25% | -28.66% | -54.36% | -40.7% | 8.01% | 11.55% | 32.57% | 32.86% | -53.85% |
| Net Income (Continuing) | -1.65M | -881.53K | -1.11M | -1.2M | -1.03M | -1.73M | -928.81K | -931.78K | -801.67K | -1.05M | -660.16K | -1.01M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -69.6K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.80 | -0.99 | -1.80 | -2.85 | -3.45 | -5.85 | -3.30 | -4.65 | -4.20 | -5.85 | -3.15 | -4.80 |
| EPS Growth % | 47.83% | 83.03% | 45.45% | 38.71% | 17.86% | 0% | -4.76% | 3.13% | 3.45% | 50% | 58.82% | 21.95% |
| EPS (Basic) | -1.80 | -0.99 | -1.80 | -2.85 | -3.45 | -5.85 | -3.30 | -4.65 | -4.20 | -5.85 | -3.15 | -4.80 |
| Diluted Shares Outstanding | 913.95K | 887.88K | 622.09K | 418.65K | 298.96K | 298.96K | 286.79K | 203.51K | 191.13K | 193.75K | 207.25K | 210.26K |
| Basic Shares Outstanding | 913.95K | 887.88K | 622.09K | 418.65K | 298.96K | 298.96K | 286.79K | 203.51K | 191.13K | 193.75K | 207.25K | 210.26K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |